FrancophonIA/ELRC3.0 huggingface dataset:
English: In the first CIDP study, a prospective multicenter open label trial (Privigen impact on mobility and autonomy PRIMA study), 28 patients (13 subjects who have previously received IVIG and 15 subjects not) were treated with a Privigen loading dose of 2g/kg bw given over 2-5 days followed by 6 maintenance doses of 1g/kg bw over 1-2 days every three weeks.
Croatian: U prvom ispitivanju KUDP, prospektivnom multicentričnom otvorenom ispitivanju (PRIMAPrivigen impact on mobility and autonomy study), 28 bolesnika (njih 13 koji su prethodno primali i.v.Ig i 15 koji nisu) liječeni su udarnom dozom Privigena od 2 g/kg TT davanoj tijekom 2-5 dana nakon čega slijedi šest doza održavanja od 1 g/kg TT tijekom 1 do 2 dana svaka tri tjedna.
English: Symptoms typically appear within 1 to 6 hours after receiving treatment.
Croatian: Simptomi se obično javljaju unutar 1 do 6 sati nakon primitka terapije.
English: Because the solution contains no preservative, Privigen should be infused as soon as possible.
Croatian: Budući da otopina ne sadrži konzervanse, Privigen treba primijeniti infuzijom što je prije moguće.
English: It is distributed relatively rapidly between plasma and extravascular fluid, after approximately 3-5 days equilibrium is reached between the intra- and extravascular compartments.
Croatian: Ravnoteža između intra- i ekstravaskularnih odjeljaka se postiže nakon približno tri do pet dana.
English: In the case of measles, this impairment may persist for up to 1 year.
Croatian: U slučaju morbila, to umanjivanje djelotvornosti cjepiva može potrajati do jedne godine.
English: There is clinical evidence of an association between IVIg administration and thromboembolic events such as myocardial infarction, cerebral vascular accident (including stroke), pulmonary embolism and deep vein thromboses which is assumed to be related to a relative increase in blood viscosity through the high influx of immunoglobulin in at-risk patients.
Croatian: Postoje klinički podaci koji potvrđuju povezanost i.v.Ig primjene i tromboembolijskih događaja kao što su infarkt miokarda, cerebralni krvožilni događaj (uključujući i moždani udar), plućna embolija i duboka venska tromboza za koje se smatra da su povezani s relativnim povećanjem viskoznosti krvi zbog visokog dotoka imunoglobulina u rizičnih bolesnika.
English: In the pivotal PID study, 80 patients were enrolled and treated with Privigen.
Croatian: U pivotalnom ispitivanju PID-a bilo je uključeno 80 bolesnika koji su se liječili Privigenom.
English: Routine laboratory tests may commonly reveal changes to liver functions (hyperbilirubinaemia) as well as changes in blood count (e.g. Coombs' (direct) test positive), increased alanine aminotransferase, increased aspartate aminotransferase, increased blood lactate dehydrogenase).
Croatian: Rutinski laboratorijski testovi mogu obično otkriti promjene funkcije jetre (hiperbilirubinemija) kao i promjene u krvnoj slici (npr. Pozitivni (direktni) Coombs-ov test) , povišenu alanin aminotransferazu, povišenu aspartat aminotransferazu), povišenu laktat dehidrogenazu u krvi.
English: Immunoglobulins are excreted into the milk and may contribute to protecting the neonate from pathogens which have a mucosal portal of entry.
Croatian: Imunoglobulini se izlučuju u majčino mlijeko i mogu pridonijeti zaštiti novorođenčeta od patogena koji u organizam ulaze preko sluznica.
English: What Privigen is used for
Croatian: Za što se Privigen koristi
English: Cerebrospinal fluid studies are frequently positive with pleocytosis up to several thousand cells per mm3, predominantly from the granulocytic series, and elevated protein levels up to several hundred mg/dl.
Croatian: Pleocitoza do nekoliko tisuća stanica po mm3, pretežno granulocitne loze, i povišene razine proteina do nekoliko stotina mg/dl su često prisutni u cerebrospinalnoj tekućini.
English: Privigen 100 mg/ml solution for infusion
Croatian: Privigen 100 mg/ml otopina za infuziju
English: Myalgia (including muscle spasms, musculoskeletal stiffness, musculoskeletal pain)
Croatian: Mialgija (uključujući grčeve mišića, mišićnokoštanu ukočenost, mišićno-koštanu bol)
English: Rarely, human normal immunoglobulin can induce a fall in blood pressure with anaphylactoid reaction, even in patients who had tolerated previous treatment with human normal immunoglobulin.
Croatian: U rijetkim slučajevima, ljudski normalni imunoglobulini mogu uzrokovati pad krvnog tlaka s anafilaktoidnom reakcijom, čak i u bolesnika koji su već podnosili liječenje ljudskim normalnim imunoglobulinom.
English: Chronic inflammatory demyelinating polyneuropathy (CIDP)* The recommended starting dose is 2 g/kg bw divided over 2 to 5 consecutive days followed by maintenance doses of 1 g/kg bw over 1 to 2 consecutive days every 3 weeks.
Croatian: Kronična upalna demijelinizirajuća polineuropatija (KUDP)* Preporučena početna doza je 2 g/kg TT podijeljena tijekom 2 do 5 uzastopnih dana nakon čega slijedi doza održavanja od 1 g/kg TT tijekom 1 do 2 uzastopna dana svaka 3 tjedna.
English: Patients may experience effects, such as dizziness or nausea, during treatment with Privigen that might affect the ability to drive and use machines.
Croatian: Bolesnici tijekom liječenja lijekom Privigen mogu primijetiti nuspojave poput omaglice ili mučnine koje mogu utjecati na sposobnost upravljanja vozilima i rada sa strojevima.
English: Multifocal Motor Neuropathy (MMN)
Croatian: Multifokalna motorička neuropatija (MMN)
English: In the PID extension study, 55 patients were enrolled and treated with Privigen.
Croatian: U nastavku ispitivanja PID-a bilo je uključeno 55 bolesnika koji su se liječili Privigenom.
English: Human normal immunoglobulin should be infused intravenously at an initial infusion rate of 0.3 ml/kg bw/hr for approximately 30 min.
Croatian: Ljudski normalni imunoglobulin treba primijeniti intravenskom infuzijom pri početnoj brzini infuzije od 0,3 ml/kg TT po satu tijekom približno 30 minuta.
English: Despite these measures, when medicines prepared from human blood or plasma are administered, the possibility of passing on infection cannot be totally excluded.
Croatian: Usprkos tim mjerama, kada se primjenjuju lijekovi iz krvi ili plazme ne može se u potpunosti isključiti mogućnost prijenosa infekcije.
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING VIAL
Croatian: PODACI KOJI SE MORAJU NALAZITI NA UNUTARNJEM PAKIRANJU
English: 1038 infusions were administered, 272 (in 16 patients) in the 3-week schedule and 766 (in 64 patients) in the 4-week schedule.
Croatian: bolesnika) u 3-tjednom rasporedu i 766 (kod 64 bolesnika) u 4-tjednom rasporedu.
English: Certain adverse reactions may occur more frequently: - in case of high rate of infusion, - in patients with hypogammaglobulinaemia or agammaglobulinaemia, with or without IgA deficiency, - in patients who receive human normal immunoglobulin for the first time or, in rare cases, when the human normal immunoglobulin product is switched or when there has been a long interval since the previous infusion.
Croatian: - u bolesnika s hipogamaglobulinemijom ili agamaglobulinemijom, sa ili bez nedostatka IgA - u bolesnika koji prvi put primaju ljudski normalni imunoglobulin ili, rijetko, pri promjeni ljudskog normalnog imunoglobulina, ili kada je prošao duži vremenski interval od prethodne infuzije.
English: There is reassuring clinical experience regarding the lack of hepatitis A or parvovirus B19 transmission with immunoglobulins and it is also assumed that the antibody content makes an important contribution to the viral safety.
Croatian: Postoje ohrabrujuća klinička iskustva o tome kako se imunoglobulinima ne prenosi hepatitis A ili parvovirus B19, a također se pretpostavlja da protutijela pridonose obrani od virusa.
English: Decreased haemoglobin (including decreased red blood cell count, decreased haematocrit), Coombs` (direct) test positive, increased alanine aminotransferase, increased aspartate aminotransferase, increased blood lactate dehydrogenase
Croatian: Sniženi hemoglobin (uključujući sniženi broj crvenih krvnih stanica, sniženi hematokrit), pozitivni Coombsov (direktni) test, povišena alanin aminotransferaza, povišena aspartat aminotransferaza, povišena razina laktat dehidrogenaze u krvi
English: Subjects all with IVIg pretreatment of at least 8 weeks and with an IVIg-dependence confirmed by clinically evident deterioration during an IVIg withdrawal phase of up to 12 weeks, received a Privigen loading dose of 2 g/kg bw followed by up to 4 Privigen maintenance doses of 1 g/kg bw every 3 weeks for up to 13 weeks.
Croatian: Bolesnici prethodno liječeni i.v.Ig-om tijekom najmanje 8 tjedana i s i.v.Ig ovisnošću potvrđenom očitim kliničkim pogoršavanjem tijekom faze ustezanja primjene i.v.Ig-a do 12 tjedana primili su udarnu dozu Privigena od 2 g/kg TT, a potom i do četiri doze održavanja Privigena od 1 g/kg TT svaka 3. tjedna do 13. tjedna.
English: You will recognize TRALI by severe difficulty in breathing (respiratory distress), abnormally low level of oxygen in the blood (hypoxemia), normal heart function (left ventricular function) and increased body temperature (fever).
Croatian: Akutnu ozljedu pluća povezanu s transfuzijom prepoznat će te po teškim poteškoćama u disanju (respiratorni distres), abnormalno niskoj razini kisika u krvi (hipoksemija), normalnom radu srca (funkcija lijeve klijetke) i povišenoj tjelesnoj temperaturi (vrućica).
English: IVIg products have been shown to cross the placenta, increasingly during the third trimester.
Croatian: Pokazano je da i.v.Ig lijekovi prolaze posteljicu, i to povećano nakon trećeg tromjesečja.
English: There are no data on pharmacokinetic properties in paediatric patients with CIDP.
Croatian: Nema podataka o farmakokinetičkim svojstvima u pedijatrijskih bolesnika s
English: Such side effects may occur even if you have previously received human immunoglobulins and tolerated them well.
Croatian: Nuspojave se mogu javiti čak i ako ste prije primali humane imunoglobuline i ako ste ih dobro podnosili.
English: Haemolytic anaemia can develop subsequent to IVIg therapy due to enhanced RBC sequestration.
Croatian: Hemolitička anemija se može razviti nakon i.v.Ig terapije zbog olakšane sekvestracije eritrocita.
English: Marketing Authorisation Holder and Manufacturer CSL Behring GmbH
Croatian: Nositelj odobrenja za stavljanje lijeka u promet: CSL Behring GmbH
English: Aseptic meningitis
Croatian: Aseptički memingitis
English: CSL Behring GmbH, D-35041 Marburg, Germany
Croatian: CSL Behring GmbH, D-35041 Marburg, Njemačka
English: If dilution prior to infusion is desired, Privigen may be diluted with 5% glucose solution to a final concentration of 50 mg/ml (5%).
Croatian: Kad je prije infuzije potrebno razrjeđenje, Privigen se može razrijediti s 5%-tnom otopinom glukoze na konačnu koncentraciju od 50 mg/ml (5%).
English: Transfusion related acute lung injury
Croatian: Akutna ozljeda pluća povezana s transfuzijom
English: Caution should be exercised in prescribing and infusing IVIg in obese patients and in patients with pre-existing risk factors for thrombotic events (such as advanced age, hypertension, diabetes mellitus and a history of vascular disease or thrombotic episodes, patients with acquired or inherited thrombophilic disorders, patients with prolonged periods of immobilisation, severely hypovolaemic patients, patients with diseases which increase blood viscosity).
Croatian: Potreban je oprez u propisivanju i primjeni infuzije i.v.Ig-a u pretilih bolesnika i u bolesnika s postojećim čimbenicima rizika za trombotične događaje (poodmakla životna dob, hipertenzija, šećerna bolest, anamneza krvožilnih bolesti ili trombotičnih epizoda, bolesnici sa stečenim ili nasljednim trombofiličnim poremećajem, bolesnici s produljenim razdobljima imobilizacije, bolesnici s teškom hipovolemijom te bolesnici s bolestima koje povećavaju viskoznost krvi).
English: Immunoglobulin administration may impair for a period of at least 6 weeks and up to 3 months the efficacy of live attenuated virus vaccines such as measles, rubella, mumps, and varicella.
Croatian: Primjena imunoglobulina može umanjiti djelotvornost cjepiva koja sadrže žive atenuirane viruse kao što su to morbili, rubela, parotitis i varičela u razdoblju od najmanje 6 tjedana do 3 mjeseca.
English: 1 vial (2.5 g/25 ml, 5 g/50 ml, 10 g/100 ml, 20 g/200 ml or 40 g/400 ml), 3 vials (10 g/100 ml or 20 g/200 ml).
Croatian: 1 bočica (2,5 g/25 ml, 5 g/50 ml, 10 g/100 ml, 20 g/200 ml ili 40 g/400 ml), 3 bočice (10 g/100 ml ili 20 g/200 ml).
English: The dose required to achieve a trough level of 5 to 6 g/l is of the order of 0.2 to 0.8 g/kg bw/month.
Croatian: Doza potrebna za postizanje najniže razine od 5-6 g/l iznosi 0,2-0,8 g/kg tjelesne težine/mjesec.
English: Tell your doctor prior to treatment.
Croatian: Prije liječenja obavijestite svog liječnika.
English: Additional measures of CIDP improvement were an increase in R-ODS (Rasch-built Overall Disability Scale) score of ≥ 4 points, a mean grip strength increase of ≥ 8 kPa, or an MRC sum score increase of ≥ 3 points.
Croatian: od ≥ 4 boda, srednja vrijednost povećanja snage hvata od ≥ 8 kPa ili povećanje MRC ukupnog rezultata za ≥ 3 boda.
English: It is strongly recommended that every time Privigen is administered to a patient, the name and batch number of the product are recorded in order to maintain a link between the patient and the batch of the product.
Croatian: Preporučuje se pri svakoj primjeni Privigenom zabilježiti naziv i broj serije lijeka, u svrhu praćenja povezanosti između bolesnika i serije lijeka.
English: The duration of treatment beyond 25 weeks should be subject to the physician's discretion based upon the patient response and maintenance response in the long-term.
Croatian: Na liječniku je da odluči želi li nastaviti liječenje dulje od 25 tjedna na temelju bolesnikova odgovora i održavanja postignutog odgovora na dulje vrijeme.
English: Patients with an acquired immunodeficiency (SID) who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure or serum IgG level of <4 g/l.
Croatian: bolesnici sa stečenom imunodeficijencijom (SID) s teškim ili ponavljajućim infekcijama, onih u kojih antimikrobno liječenje nije bilo učinkovito te s dokazanim nedostatkom stvaranja specifičnog antitijela ili s koncentracijom IgG-a u serumu <4 g/l.
English: Aseptic meningitis syndrome has been reported to occur in association with IVIg treatment.
Croatian: Sindrom aseptičnog meningitisa (AMS) Sindrom aseptičnog meningitisa prijavljen je u vezi s liječenjem i.v.Ig-om.
English: Because the solution contains no preservative, Privigen should be infused immediately.
Croatian: S obzirom da otopina ne sadrži konzervanse, Privigen treba odmah primijeniti infuzijom.
English: Privigen comes as a ready-to-use solution in single-use vials.
Croatian: Privigen se isporučuje kao otopina spremna za uporabu u bočicama za jednokratnu uporabu.
English: Cases of reversible aseptic meningitis and rare cases of transient cutaneous reactions (including cutaneous lupus erythematosus - frequency unknown) have been observed with human normal immunoglobulin including Privigen.
Croatian: Kod primjene normalnog ljudskog imunoglobulina uključujući Privigen zabilježene su slučajevi reverzibilnog aseptičkog meningitisa i rijetki slučajevi prolaznih kožnih reakcija (uključujući kožni eritemski lupus - učestalost nepoznata).
English: IVIg products can contain blood group antibodies which may act as haemolysins and induce in vivo coating of red blood cells (RBC) with immunoglobulin, causing a positive direct antiglobulin reaction (Coombs' test) and, rarely, haemolysis.
Croatian: Hemolitička anemija i.v.Ig lijekovi mogu sadržavati protutijela na krvne grupe koja mogu reagirati kao hemolizini i in vivo dovesti do oblaganja eritrocita imunoglobulinom uzrokujući tako pozitivnu direktnu antiglobulinsku reakciju (Coombsov test) i rijetko hemolizu.
English: Clinical experience with immunoglobulins suggests that no harmful effects on the course of pregnancy, or on the foetus and the neonate are to be expected.
Croatian: Prema kliničkim iskustvima s primjenom imunoglobulina ne treba očekivati štetne učinke tijekom trudnoće na fetus ili na novorođenče.
English: The recommended starting dose is 0.4 to 0.8 g/kg body weight (bw) given once, followed by at least 0.2 g/kg bw every 3 to 4 weeks.
Croatian: Preporučena početna doza iznosi 0,4-0,8 g/kg tjelesne težine (TT) jednokratno, a zatim svaka 3 do 4 tjedna treba primijeniti dozu od najmanje 0,2 g/kg TT.
English: Emil-von-Behring-Strasse 76 D-35041 Marburg Germany
Croatian: Emil-von-Behring-Strasse 76 D-35041 Marburg
English: In PID patients who have tolerated the infusion rate of 4.8 ml/kg bw/hr well, the rate may be further increased gradually to a maximum of 7.2 ml/kg bw/hr.
Croatian: U PID bolesnika koji su dobro podnijeli brzinu infuzije od 4,8 ml/kg TT/sat, brzina infuzije se može postupno povećati na najviše 7,2 ml/kg TT/sat.
English: 0.2 - 0.4 g/kg bw every 3 to 4 weeks
Croatian: 0,2 - 0,4 g/kg TT svaka 3 do 4 tjedna
English: EU/1/08/446/001 5 g/50 ml EU/1/08/446/002 10 g/100 ml EU/1/08/446/003 20 g/200 ml EU/1/08/446/004 2.5 g/25 ml EU/1/08/446/005 10 g/100 ml (3 vial pack size) EU/1/08/446/006 20 g/200 ml (3 vial pack size) EU/1/08/446/007 40 g/400 ml
Croatian: EU/1/08/446/001 5 g/50 ml EU/1/08/446/002 10 g/100 ml EU/1/08/446/003 20 g/200 ml EU/1/08/446/004 2,5 g/25 ml EU/1/08/446/005 10 g/100 ml (pakiranje od 3 bočice) EU/1/08/446/006 20 g/200 ml (pakiranje od 3 bočice) EU/1/08/446/007 40 g/400 ml
English: Temporary lowering of red blood cell count (anaemia), breakdown of red blood cells (haemolysis), decreased number of white blood cells (leukopenia), hypersensitivity, dizziness (including vertigo), high blood pressure (hypertension), flushing (including hot flush, hyperaemia), hypotension (including decreased blood pressure), breathlessness (dyspnoea including chest pain, chest discomfort, painful breathing), vomiting, loose stools (diarrhea), stomach pain, skin disorder (including rash, itching (pruritus), hives (urticaria), maculopapular rash, redness of the skin (erythema), peeling of the skin (skin exfoliation)), pain in the muscles (including muscle cramps and rigidity), tiredness (fatigue), physical weakness (asthenia), weakness in the muscles, .
Croatian: (hemoliza), smanjenje broja bijelih krvnih stanica (leukopenija), preosjetljivost, omaglica (uključujući vrtoglavicu), visoki krvni tlak (hipertenzija), navale crvenila (uključujući valunge, hiperemiju), hipotenzija (uključujući sniženi krvni tlak), nedostatak zraka (dispneja, uključujući bol u prsištu, nelagodu u prsištu, bolno disanje, povraćanje, rijetka stolica (dijareja), bol u trbuhu, poremećaji kože (uključujući osip, svrbež (pruritus), koprivnjaču (urtikariju), makopapilarni osip, crvenilo kože (eritema), ljuštenje kože (eksfolijaciju kože)), bol u mišićima (uključujući grčeve i ukočenost), umor, fizička slabost (astenija), slabost u mišićima.
English: Sodium content Privigen is essentially sodium-free.
Croatian: Sadržaj natrija Privigen u osnovi ne sadrži natrij.
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČ BIOLOŠKE DJELATNE TVARI I PROIZVOĐAČ(I) ODGOVORAN(ODGOVORNI) ZA PUŠTANJE SERIJE LIJEKA U PROMET
English: - Multifocal motor neuropathy (MMN)
Croatian: - Multifokalna motorička neuropatija (MMN).
English: 1.6 - 2 g/kg bw or in divided doses over 2 to 5 days in association with acetylsalicylic acid
Croatian: 1,6 - 2 g/kg TT ili u podijeljenim dozama tijekom 2 do 5 dana u kombinaciji s acetilsalicilatnom kiselinom2 g/kg TT u jednoj dozi u kombinaciji s acetilsalicilatnom kiselinom
English: Within each frequency grouping, undesirable effects are presented in order of decreasing frequency.
Croatian: Unutar svake skupine učestalosti, nuspojave su prikazane u padajućem nizu prema učestalosti.
English: For obtaining an immunoglobulin solution of 50 mg/ml (5%), Privigen 100 mg/ml (10%) should be diluted with an equal volume of the glucose solution.
Croatian: Za dobivanje otopine imunoglobulina od 50 mg/ml (5%), potrebno je razrijediti Privigen 100 mg/ml (10%) s jednakim volumenom otopine glukoze.
English: This is a chronic disease that is characterised by inflammation of the peripheral nerves that causes muscle weakness and/or numbness mainly in the legs and upper limbs.
Croatian: To je kronična bolest koju karakterizira upala perifernih živaca što uzrokuje slabost i/ili obamrlost mišića uglavnom u nogama i rukama. pacijenti s multifokalnom motoričkom neuropatijom (MMN).
English: Overdose is very unlikely to occur because Privigen is usually administered under medical supervision.
Croatian: Privigen se obično primjenjuje pod liječničkim nadzorom, stoga je vrlo vjerojatno da do predoziranja neće doći.
English: Chronic inflammatory demyelinating polyneuropathy (CIDP)*
Croatian: Kronična upalna demijelinizirajuća polineuropatija (KUDP)*
English: In case of adverse reaction, either the rate of administration must be reduced or the infusion stopped.
Croatian: U slučaju neželjenih reakcija, potrebno je ili smanjiti brzinu infuzije ili u potpunosti obustaviti infuziju.
English: The overall median time to first MRC sum score response in PRIMA was 6 weeks (6 weeks in the IVIg-untreated and 3 weeks in the IVIg-pretreated) and 9.3 weeks in PATH.
Croatian: Ukupni median vremena do prvog odgovora prema ukupnom rezultatu MRC-a u PRIMA-i bilo je 6 tjedana (6 tjedana u prethodno neliječenih i.v.
English: • temporary non-infectious meningitis (reversible aseptic meningitis), Tell your doctor or healthcare professional immediately if you have a stiff neck together with one or more of the following symptoms: fever, nausea, vomiting, headache, abnormal sensitivity to light, mental disturbances.
Croatian: Odmah obavijestite svog liječnika ili zdravstvenog radnika ako imate ukočen vrat skupa s jednim ili više od sljedećih simptoma: vrućicu, mučninu, povraćanje, glavobolju, nenormalnu osjetljivost na svjetlost, mentalne poremećaje.
English: • In very rare cases transfusion-related acute lung injury (TRALI) can occur after receiving immunoglobulins including Privigen.
Croatian: • U vrlo rijetkim slučajevima se nakon primitka imunoglobulina uključujući Privigen može pojaviti akutna ozljeda pluća povezana s transfuzijom.
English: • You are diabetic.
Croatian: • Ako imate šećernu bolest.
English: CSL Behring GmbH Emil-von-Behring-Strasse 76 D-35041 Marburg Germany
Croatian: CSL Behring GmbH Emil-von-Behring-Strasse 76 D-35041 Marburg
English: Hypertension, flushing (including hot flush, hyperaemia), hypotension
Croatian: Hipertenzija, navala crvenila (uključujući valunge, hiperemiju), hipotenzija
English: For obtaining an immunoglobulin solution of 50 mg/ml (5%), Privigen 100 mg/ml (10%) should be diluted with an equal volume of the 5% glucose solution.
Croatian: Za dobivanje otopine imunoglobulina od 50 mg/ml (5%) potrebno je razrijediti Privigen 100 mg/ml (10%) s jednakim volumenom 5% -tne otopine glukoze.
English: Headache (including sinus headache, migraine, head discomfort, tension headache)
Croatian: Glavobolja (uključujući sinusnu glavobolju, migrenu, nelagodu u glavi, tenzijsku glavobolju),